Floatz logo

Therapeutic Asset Ratings

766 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[68ga]ga-nota-t4
Prostate Cancer
RenJi HospitalP2/3CCC (48)
[68ga]ga-nota-t4
Neoplasm
RenJi HospitalP2/3CCC (48)
[68ga]p16-093
Prostate Cancer
Five Eleven Pharma, Inc.P1/2CCC (48)
68ga-p16-093
Prostate Cancer
Peking Union Medical College HospitalP2/3CCC (48)
68ga-p16-093
Prostate Adenocarcinoma
First Affiliated Hospital of Fujian Medical UniversityP1/2CCC (48)
CAM-H2
Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
PrecirixP1/2CCC (48)
Lutetium-177-Dotaga-Iac
Breast Cancer
Advanced Imaging Projects, LLCP1/2CCC (48)
Rhenium Liposome Treatment
Glioma
Plus TherapeuticsP1/2CCC (48)
Tb-Psma-I&T
Prostate Cancer
Rabin Medical CenterP1/2CCC (48)
Yttrium-90
Disease Related To Solid Organ Transplantation
University Health Network, TorontoP1/2CCC (48)
123i-att001
Glioblastoma
Theragnostics LtdP1CC (47)
177Lu-LNC1004
Solid Tumor, Unspecified, Adult
Yantai LNC Biotechnology Singapore PTE. LTD.P1CC (47)
[18f]ucb-2897
Multiple System Atrophy
InvicroP1CC (47)
[68ga]ga-oncofap administration
Esophageal Cancer
Philogen S.p.A.P1CC (47)
68ga-lnc1007
Cancer
Yantai LNC Biotechnology Singapore PTE. LTD.P1CC (47)
68ga-r10602
Hormone Receptor-Positive Breast Cancer
Radionetics OncologyP1CC (47)
Gallium-68 Labelled Fap-2286
Myocardial Fibrosis
Thomas HopeP1CC (47)
[111in]-fpi-1967
Urinary Bladder Carcinoma
Fusion Pharmaceuticals Inc.P1/2CC (47)
177lu-betabart
Castration-Resistant Prostate Carcinoma
Radiopharm Theranostics, LtdP1/2CC (47)
177lu-betabart
Triple-Negative Breast Carcinoma
Radiopharm Theranostics, LtdP1/2CC (47)
177lu htk03170
Castration-Resistant Prostate Carcinoma
British Columbia Cancer AgencyP1/2CC (47)
[177lu]lu-dpi-4452
Non-Small Cell Squamous Lung Carcinoma
ITM Oncologics GmbHP1/2CC (47)
[177lu]lu-sn201
Unresectable Solid Tumor
Spago Nanomedical ABP1/2CC (47)
[212pb]pb-mp0712
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Molecular Partners AGP1/2CC (47)
[212pb]vmt01
Melanoma
Perspective TherapeuticsP1/2CC (47)
Showing 176 to 200 of 766 assets
PreviousPage 8 of 31Next